Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge

Journal of Infectious Diseases

Volumn 185, Issue 11, 2002, Pages 1550-1560

  Evans, Ingrid A C ^a   Jones, Cheryl A ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; HERPES SIMPLEX VACCINE; IMMUNOGLOBULIN G ANTIBODY; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX VIRUS 2; IMMUNIZATION; INFECTION SENSITIVITY; MATERNAL TREATMENT; MOUSE; NEWBORN; NEWBORN INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPLEEN CELL; TRIGEMINAL NERVE; ULTRAVIOLET RADIATION; VIRUS ENCEPHALITIS; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; DEFECTIVE VIRUSES; ENCEPHALITIS, HERPES SIMPLEX; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; IMMUNIZATION; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRAL VACCINES; VIRUS REPLICATION; VISCERA;

EID: 0036605896     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340572     Document Type: Article

References (57)

1. Neonatal herpes simplex virus infections
2. Neonatal herpes simplex virus infection in King County, Washington: Increasing incidence and epidemiologic correlates
3. The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995
4. Neonatal herpes simplex virus infection
5. Neonatal herpes simplex virus infection in the British Isles
6. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants
7. A prospective study of influenza infections during pregnancy
8. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy
9. Oral polio vaccination during pregnancy: Lack of impact on fetal development and perinatal outcome
10. Effect of maternal immunization with oral poliovirus vaccine on neonatal immunity
11. Perinatal risk associated with maternal genital herpes simplex virus infection
12. The natural history of herpes simplex virus infection of mother and newborn
13. Protection of neonatal mice against herpes simplex virus infection: Probable in vivo antibody-dependent cellular cytotoxicity
14. Protection of neonatal mice against herpes simplex viral infection by human antibody and leukocytes from adult, but not neonatal, humans
15. Relationship of antibody to outcome in neonatal herpes simplex virus infections
16. Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection
17. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection
18. The acquisition of herpes simplex virus during pregnancy
19. Prospects for control of herpes simplex virus disease through immunization
20. Evaluation of a live attenuated recombinant virus RAV 9395 as a herpes simplex virus type 2 vaccine in guinea pigs
21. Immunization with replication-defective mutants of herpes simplex virus type 1: Sites of immune intervention in pathogenesis of challenge virus infection
22. Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted
23. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B
24. Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs
25. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: Two randomized controlled trials
26. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2
27. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection
28. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease
29. Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection
30. Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model
31. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge
32. Characterization of herpes simplex virus 2 temperature-sensitive mutants whose lesions map in or near the coding sequences for the major DNA-binding protein
33. Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2
34. Definition of a series of stages in the association of two herpesvirul proteins with the cell nucleus
35. Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants
36. Neonatal and early life vaccinology
37. Herpes simplex virus infections of women and their offspring: Implications for a developed society
38. Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine
39. Herpes simplex virus type 2 infection of neonatal mice
40. An experimental model for disseminated herpesvirus infection of the neonate
41. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2
42. The role of herpes simplex thymidine kinase expression in neurovirulence and latency in newborn vs. adult mice
43. Intracerebral inoculation of newborn and adult mice with thymidine kinase-deficient mutants of herpes simplex virus type 1
44. Analysis of the relationship between cellular thymidine kinase activity and virulence of thymidine kinase-negative herpes simplex virus types 1 and 2
45. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate
46. Acyclovir-resistant neonatal herpes simplex virus infection of the larynx
47. The relative role of transplacental and milk immune transfer in protection against lethal neonatal herpes simplex virus infection in mice
48. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2
49. Ontogeny of murine cellular cytotoxicity to herpes simplex virus-infected cells
50. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B
51. Herpes simplex viremia: Report of eight pediatric cases and review of the literature
52. Detection of viral DNA in neonatal herpes simplex virus infections: Frequent and prolonged presence in serum and cerebrospinal fluid
53. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum
54. Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells
55. Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro
56. Fatal viral encephalitis in children with X-linked hypogammaglobulinemia
57. Cell-to-cell transmission of herpes simplex virus in primary human amnion cells